Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Spring;7(1):40-53.

Pathogenesis of atherosclerosis: A multifactorial process

Affiliations

Pathogenesis of atherosclerosis: A multifactorial process

Raja B Singh et al. Exp Clin Cardiol. 2002 Spring.

Abstract

Atherosclerosis is a leading cause of mortality and morbidity in the western world. It has been recognized for over a century, and the understanding of its pathogenesis has undergone many changes. Pathophysiological studies have unravelled the interactions of molecular and cellular elements involved in atherogenesis. The focus has shifted to the novel risk factors as well as characteristics and stability of atherosclerotic plaque; the genetic predisposition has further broadened the pathogenetic mechanisms. This review focuses on the molecular mechanisms involved in the evolution of the atherosclerotic plaque that may pave the way for selecting optimal therapies and preventing plaque complications. Atherosclerosis is no longer a disease attributed mainly to the high lipid content of the body. New insight into the disease pathology has shown it to be a disease of much greater ramifications. Endothelial damage and reactive oxygen species (and other free radicals) have predominantly emerged as factors in virtually all pathways leading to the development of atherosclerosis due to hyperlipidemia, diabetes, hypertension or smoking. Novel risk factors such as hyperhomocysteinemia, infections and systemic lupus erythematosus have emerged. Atherosclerosis has come to be regarded as a chronic inflammatory disease with an autoimmune component. The genetic basis of the disease assumes significance as candidate genes are identified and gene therapy becomes a promising new addition to the existing, less substantial conventional therapies.

Keywords: Angiotensin; Atherogenesis; Cytokines; Growth factors; Oxidized low density lipoproteins; Plaque formation; Reactive oxygen species.

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
Schematic design depicting the involvement of oxidized low density lipoprotein (oxLDL), injury of endothelial cells and proliferation of vascular smooth muscle cells (SMC) in the development of atherosclerotic plaque. MAP Mitogen-activated protein
Figure 2)
Figure 2)
Schematic diagram depicting the involvement of reactive oxygen species, endothelial dysfunction, growth factors, cytokines and adhesion molecules in the genesis of atherosclerosis. LDL Low density lipoprotein

References

    1. Hegele RA. The genetic basis of atherosclerosis. Int J Clin Lab Res. 1997;27:2–13. - PubMed
    1. Turunen MP, Hiltunen MO, Yla-Herttuala S. Gene therapy for angiogenesis, restenosis and related diseases. Exp Gerontol. 1999;34:567–74. - PubMed
    1. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 1998;104:14S–8S. - PubMed
    1. Palinski W, Napoli C. Pathophysiological events during pregnancy influence the development of atherosclerosis in humans. Trends Cardiovasc Med. 1999;9:205–14. - PubMed
    1. Napoli C, D’Armiento FP, Corso G, et al. Occurrence of the same peroxidative compounds in low density lipoprotein and in atherosclerotic lesions from a homozygous familial hypercholesterolemic patient: a case report. Int J Cardiol. 1997;62:77–85. - PubMed

LinkOut - more resources